Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

Multi-Platform Technology Provides Ideal Base for Labeled Secondary Antibodies

Released on = March 22, 2007, 10:05 am

Press Release Author = AnaSpec Inc.

Industry = Biotech

Press Release Summary = In the marketplace for labeled secondary antibodies, most
companies offer experience in either antibody technologies or labeling technologies.
With core competencies in both antibody production and detection reagents, AnaSpec
provides a multi-platform technology base that is well-suited for the production of
labeled secondary antibodies.

Press Release Body = March 12, 2007 - San Jose, CA

In the marketplace for labeled secondary antibodies, most companies offer experience
in either antibody technologies or labeling technologies. With core competencies in
both antibody production and detection reagents, AnaSpec provides a multi-platform
technology base that is well-suited for the production of labeled secondary
antibodies.

AnaSpec has established a worldwide reputation for providing high-quality AP-,
HRP-conjugated and biotinylates secondary antibodies on the market. Leveraging its
proprietary fluorescence technologies, AnaSpec line of labeled secondary antibodies
includes antibodies labeled with fluorescent reagents with the industry's highest
photostability.

AnaSpec offers secondary antibodies labeled with its proprietary HiLyte Fluor dyes
(Cy and Alexa dyes analogs) as well as secondary antibodies labeled with classic
fluorophores like TAMRA, AMCA, FAM, and FITC.

For more information visit www.anaspec.com
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to
pharmaceutical, biotech, and academic research institutions throughout the world.
With a vision for innovation through synergy, AnaSpec focuses on three core
technologies: peptides, detection reagents, and combinatorial chemistry.
AnaSpec carries a broad product line of biochemicals and reagents for basic
research, high-throughput screening and drug discovery. In conjunction, AnaSpec
provides premier custom services including peptide synthesis, antibody production,
and assay development.
Established in 1993, AnaSpec\'s headquarters and manufacturing facilities are located
in San Jose, CA. AnaSpec maintains ISO9001 certification, holds a California Drug
Manufacturing License and a FDA Registration for GMP Drug Manufacturing.


Web Site = http://www.anaspec.com

Contact Details = 2149 O\'Toole Ave.
San Jose, CA
408-452-5055
ping@anaspec.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •